Jazz Pharmaceuticals JAZZ Excess tax benefits associated with employee equity plans (in percent)
Excess tax benefits associated with employee equity plans (in percent) at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's excess tax benefits associated with employee equity plans (in percent).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's excess tax benefits associated with employee equity plans (in percent)?
- Jazz Pharmaceuticals (JAZZ) reported excess tax benefits associated with employee equity plans (in percent) of -0.8% in Q4 2025.
- What does excess tax benefits associated with employee equity plans (in percent) mean?
- The percentage reduction in the effective tax rate due to employee stock plan tax benefits.
- How do you interpret excess tax benefits associated with employee equity plans (in percent)?
- A higher percentage indicates that equity-based compensation is a more significant driver of tax efficiency.
- How does excess tax benefits associated with employee equity plans (in percent) compare across companies?
- Standard metric for companies with significant equity compensation programs; varies by stock performance and grant size.